OMRF scientists need volunteers for the world’s first lupus prevention study.
trial
A name for his pain
David Key had never heard of sarcoidosis—until the rare disease stole his health.
Oblato acquires all rights to glioblastoma drug from OMRF
Oblato, Inc., has acquired all rights from OMRF to OKN-007, an investigational drug for the treatment of a deadly form of brain cancer.
OMRF launches world’s first lupus prevention study
The SMILE trial will seek to identify individuals at high risk for developing lupus and treat them before they ever transition into the disease.
Berry benefit: Study shows strawberries might help combat osteoarthritis
Osteoarthritis is the most common form of disability in the U.S., but you might find an ally against it in the produce section.
OMRF Multiple Sclerosis Center wins top MS research award
The Scheinberg Award recognizes research excellence in the field of neurorehabiliation in MS.
